EMA Authorised: Ebixa (memantine hydrochloride) — H. Lundbeck A/S

View source ↗

Summary

European Medicines Agency authorised Ebixa (memantine hydrochloride) for Alzheimer disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Ebixa (memantine hydrochloride)

Snippet

Status: Authorised. Therapeutic area: Alzheimer Disease. MAH: H. Lundbeck A/S. Decision date: 17/12/2021